The rapid growth of research in the areas of chemical and biochemical sensors, lab-on-a-
chip, mobile technology, and wearable electronics offers an unprecedented opportunity in …

Paper-based lateral-flow assays (LFAs) have achieved considerable commercial success
and continue to have a significant impact on medical diagnostics and environmental …

The design and use of materials in the nanoscale size range for addressing medical and
health-related issues continues to receive increasing interest. Research in nanomedicine …

Cancer is one of the main causes of mortality and morbidity worldwide. However, its early
non-invasive detection via quantification of appropriate biomarkers can significantly reduce …

We review point-of-care (POC) diagnostics, in vitro diagnostic (IVD) tests that do not involve
the use of laboratory staff and facilities to provide the result. The analytical “targets” include …

Lateral flow biosensors (LFBs) are paper-based devices which permit the performance of
low-cost and fast diagnostics with good robustness, specificity, sensitivity and low limits of …

Biomarkers play a vital role in disease detection and treatment follow-up. It is important to
note that diseases in the early stage are typically treated with the greatest probability of …

Lateral-flow tests were first launched commercially in 1984, as a simple urine-based
pregnancy test for home use. The simplicity of the visual readout delivered by the basic …

Semiconductor nanoparticles, or quantum dots (QDs), have unique photophysical
properties, such as size‐controlled fluorescence, have high fluorescence quantum yields …

A portable fluorescence biosensor with rapid and ultrasensitive response for protein
biomarker has been built up with quantum dots and a lateral flow test strip. The superior …